Vascular Biogenics Ltd (VBLT)

[staccani]

David, some points i find strange
1) how could you underestand from direct experience of these 11/12 patients in vbl that they survived 10 months? Nobody is able to self report his/her survival.
2) that they would quit a trial because some had to fly. I have had direct experience of cancer trials and nobody would leave his only survival chance unless he becomes too sick to travel. But that applies to both arms
3) you mention trials where Avastin survival ranged from 7 to 10.5 months. Please cite any specific triala that Was above 10 months other than the well known nivolumab bmy trial where we know the reason (only small tumors di nrolled and btw and avg survival btw Was 10 months not 10.5)
4) you are a neurologist( i have no reason to doubt it, but i will read your previous posts to confirm it) and yet you have no other means to understand if an open label treatment is working or not other than Reading message boards instead of talking to your colleagues?
5) finally you disclosed you have not bought back yet, but you think the drug will be aporoved. Sonething tells me that you are looking for the right moment to buy back and hence the reason of your post